Scarica l'app Stockscreener
2.38
2.15%
0.05
Dopo l'orario di chiusura:
2.34
-0.04
-1.68%
Gri Bio Inc Borsa (GRI) Ultime notizie
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Options Flow: Is GRI Bio Inc forming a double bottom2026 Weekly Recap & Stepwise Trade Execution Plans - baoquankhu1.vn
Aug Technicals: Is GRI Bio Inc in a long term uptrend2026 Gainers & AI Driven Price Predictions - baoquankhu1.vn
Options Flow: Can GRI Bio Inc reach all time highs this yearTrade Exit Summary & Smart Money Movement Tracker - baoquankhu1.vn
GRI Bio (NASDAQ:GRI) versus NeoGenomics (NASDAQ:NEO) Financial Contrast - Defense World
Trend Review: Can GRI Bio Inc be recession proof2026 Market Mood & Detailed Earnings Play Strategies - baoquankhu1.vn
Portfolio Recap: Is GRI Bio Inc a top pick in the sectorMarket Activity Recap & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Outlook: Can GRI Bio Inc keep up with sector leaders2026 Final Week & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Movement Recap: Is GRI Bio Inc a momentum stock2026 Setups & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in GRI Bio (GRI) - Stock Titan
Analyst Calls: Is GRI Bio Inc a top pick in the sectorPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
AI Investing InsightsOfficial HomepageIntellectia AI™ - intellectia.ai
Aug Retail: Is HOWL a defensive stockWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn
Aug Setups: Will FWRD outperform tech stocksWeekly Trend Recap & Stock Market Timing Techniques - baoquankhu1.vn
Patterns Watch: What are CLMBs earnings expectationsEarnings Performance Report & Trade Opportunity Analysis - baoquankhu1.vn
Se espera que GRI Bio Inc registre una pérdida de 1,31 dólares por acciónAvance de resultados - TradingView
GRI Bio, Inc. Financial Disclosures & SEC Filings - TradingView
Activity Recap: Can GRI Bio Inc be recession proof2025 Pullback Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
GRI Bio (GRI) Expected to Announce Quarterly Earnings on Friday - Defense World
Update Report: What is OBLGs 5 year growth outlookJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - baoquankhu1.vn
Short Covering: What makes GRI Bio Inc stock attractive todayWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
GRI PE Ratio & Valuation, Is GRI Overvalued - Intellectia AI
Aug Drivers: Is GRI Bio Inc a top pick in the sector2025 Price Action Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
GRI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Loss Report: Is GRI Bio Inc stock a smart retirement pickWeekly Gains Report & AI Based Buy and Sell Signals - baoquankhu1.vn
Geopolitics Watch: Can GRI Bio Inc reach all time highs this yearPortfolio Growth Summary & AI Forecast Swing Trade Picks - baoquankhu1.vn
Growth Review: Is GRI Bio Inc stock a smart retirement pick2025 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Is GRI Bio Inc. a momentum stockJuly 2025 Movers & Technical Buy Zone Confirmations - mfd.ru
GRI Should I Buy - Intellectia AI
Market Leaders: What dividend growth rate does CHGG offerJuly 2025 Action & Verified Short-Term Plans - baoquankhu1.vn
Investor Mood: Is GRI Bio Inc stock a smart retirement pickQuarterly Risk Review & Real-Time Volume Surge Alerts - baoquankhu1.vn
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment - The Globe and Mail
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor 'What This Means” Segment - The Manila Times
GRI Bio, Inc. Discusses Positive Phase 2a Data in Idiopathic Pulmonary Fibrosis During Virtual Investor Segment - Quiver Quantitative
Can GRI Bio Inc. stock maintain growth trajectoryProduct Launch & AI Powered Market Entry Strategies - mfd.ru
[SCHEDULE 13G/A] GRI Bio, Inc. Amended Passive Investment Disclosure - Stock Titan
GRI Stock Down on Public Offering Despite Encouraging IPF Study Data - MSN
Is GRI Bio Inc. showing insider buyingJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - mfd.ru
GRI Bio: Positive phase 2A IPF results and IND plans for lupus program signal strong pipeline momentum - TradingView
GRI Bio: Positive phase 2A IPF data and pipeline progress position GRI Bio for key upcoming milestones - TradingView
Can GRI Bio Inc. reach all time highs this yearStock Surge & Free Growth Oriented Trading Recommendations - mfd.ru
Levels Update: Is now the right time to enter SHF Holdings IncPortfolio Value Report & Verified Momentum Stock Watchlist - baoquankhu1.vn
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - Yahoo Finance
GRI Bio CEO to detail immune cell modulator pipeline in Webull webinar Feb. 11 - Stock Titan
GRI Bio reports $8.2 million cash position, extends runway into Q1 2027 - Investing.com Canada
GRI Bio sees cash runway into 1Q27 - TipRanks
GRI Bio raises $14.5 mln to fund operations into Q1 2027 - TradingView
GRI Bio: Strong cash position and positive clinical data support continued pipeline advancement - TradingView
GRI Bio, Inc. Reports Strong Cash Position and Positive Phase 2a Results for GRI-0621 in Pulmonary Fibrosis - Quiver Quantitative
GRI Bio Reiterates Full Year 2025 Financial Results, - GlobeNewswire
GRI Bio (GRI) Price Target Increased by 2,700.00% to 656.88 - Nasdaq
Dip Buying: Is CALX forming bullish engulfing patternsForecast Cut & Free Reliable Trade Execution Plans - baoquankhu1.vn
Aug Summary: What makes GRI Bio Inc stock attractive todayJuly 2025 Rallies & Low Drawdown Trading Techniques - baoquankhu1.vn
Trading Recap: Can OACCU deliver consistent dividendsJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Gri Bio Warns of Ongoing Internal Control Weaknesses That Could Threaten Financial Reporting Reliability and Investor Confidence - TipRanks
Rate Cut: Is GRI Bio Inc forming a double bottomQuarterly Portfolio Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Buyback Watch: Is JVSPAC Acquisition Corp Equity Right a momentum stockEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
GRI Bio: 2025 net loss rose to $12M as R&D spending increased; more capital needed for future trials - TradingView
GRI Bio, Inc. SEC 10-K Report - TradingView
GRI Bio Expands At-The-Market Equity Offering Capacity - TipRanks
GRI Bio May Offer Up To $250 Million In SecuritiesSEC Filing - TradingView
Movement Recap: Can GRI Bio Inc be recession proof2025 Bull vs Bear & Weekly High Return Forecasts - baoquankhu1.vn
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):